161 related articles for article (PubMed ID: 24149323)
1. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
Yan W; Wu K; Herman JG; Brock MV; Fuks F; Yang L; Zhu H; Li Y; Yang Y; Guo M
Epigenetics; 2013 Dec; 8(12):1373-83. PubMed ID: 24149323
[TBL] [Abstract][Full Text] [Related]
2. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract][Full Text] [Related]
3. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
[TBL] [Abstract][Full Text] [Related]
4. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract][Full Text] [Related]
5. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
[TBL] [Abstract][Full Text] [Related]
6. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.
Dong Y; Cao B; Zhang M; Han W; Herman JG; Fuks F; Zhao Y; Guo M
Oncotarget; 2015 Sep; 6(26):22126-38. PubMed ID: 26124080
[TBL] [Abstract][Full Text] [Related]
8. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer.
Boughanem H; Cabrera-Mulero A; Hernández-Alonso P; Clemente-Postigo M; Casanueva FF; Tinahones FJ; Morcillo S; Crujeiras AB; Macias-Gonzalez M
Clin Epigenetics; 2020 Jun; 12(1):83. PubMed ID: 32517740
[TBL] [Abstract][Full Text] [Related]
9. Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis.
Helmer RA; Martinez-Zaguilan R; Kaur G; Smith LA; Dufour JM; Chilton BS
PLoS One; 2021; 16(5):e0251132. PubMed ID: 34010296
[TBL] [Abstract][Full Text] [Related]
10. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
Li Z; Jiao X; Robertson AG; Di Sante G; Ashton AW; DiRocco A; Wang M; Zhao J; Addya S; Wang C; McCue PA; South AP; Cordon-Cardo C; Liu R; Patel K; Hamid R; Parmar J; DuHadaway JB; Jones SJM; Casimiro MC; Schultz N; Kossenkov A; Phoon LY; Chen H; Lan L; Sun Y; Iczkowski KA; Rui H; Pestell RG
Oncogene; 2023 Jun; 42(22):1857-1873. PubMed ID: 37095257
[TBL] [Abstract][Full Text] [Related]
11. Study of DACH1 Expression and its Epigenetic Regulators as Possible Breast Cancer-Related Biomarkers.
Nasirpour MH; Salimi M; Majidi F; Minuchehr Z; Mozdarani H
Avicenna J Med Biotechnol; 2023; 15(2):108-117. PubMed ID: 37034893
[TBL] [Abstract][Full Text] [Related]
12. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W
Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498
[TBL] [Abstract][Full Text] [Related]
13. Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer.
Bao-Caamano A; Costa-Fraga N; Cayrefourcq L; Jácome MA; Rodriguez-Casanova A; Muinelo-Romay L; López-López R; Alix-Panabières C; Díaz-Lagares A
Sci Rep; 2023 Sep; 13(1):15401. PubMed ID: 37717096
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ABCC3 activates MAPK signaling through accumulation of deoxycholic acid in colorectal cancer cells.
Sato Y; Kobayashi M; Ohira M; Funayama R; Maekawa M; Karasawa H; Kashiwagi R; Aoyama Y; Mano N; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2024 Jun; 115(6):1778-1790. PubMed ID: 38566304
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box E1, frequently downregulted by promoter methylation, inhibits colorectal cancer cell growth and migration.
Shi Q; Huang Z; Kuang Y; Wang C; Fang X; Hu X
Cancer Cell Int; 2024 May; 24(1):169. PubMed ID: 38734646
[TBL] [Abstract][Full Text] [Related]
16. Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies.
Tortolina L; Duffy DJ; Maffei M; Castagnino N; Carmody AM; Kolch W; Kholodenko BN; De Ambrosi C; Barla A; Biganzoli EM; Nencioni A; Patrone F; Ballestrero A; Zoppoli G; Verri A; Parodi S
Oncotarget; 2015 Mar; 6(7):5041-58. PubMed ID: 25671297
[TBL] [Abstract][Full Text] [Related]
17. Methylation-Based Therapies for Colorectal Cancer.
Cervena K; Siskova A; Buchler T; Vodicka P; Vymetalkova V
Cells; 2020 Jun; 9(6):. PubMed ID: 32599894
[TBL] [Abstract][Full Text] [Related]
18. Methylated
Li J; Zhou C; Ni S; Wang S; Ni C; Yang P; Ye M
Oncotarget; 2017 Nov; 8(56):96249-96262. PubMed ID: 29221203
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis.
Doke T; Huang S; Qiu C; Liu H; Guan Y; Hu H; Ma Z; Wu J; Miao Z; Sheng X; Zhou J; Cao A; Li J; Kaufman L; Hung A; Brown CD; Pestell R; Susztak K
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998598
[TBL] [Abstract][Full Text] [Related]
20. DACH1 as a multifaceted and potentially druggable susceptibility factor for kidney disease.
Merscher S; Faul C
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
